Brief: PDS Biotechnology Corp Patent For Composition Of Matter And Use Of Infectimune Based Influenza Vaccines Granted In The United States
13/03/2024 10:23
March 13 (Reuters) - PDS Biotechnology Corp PDSB.O :
* PDS BIOTECHNOLOGY CORP: PATENT FOR COMPOSITION OF MATTER
AND USE
OF INFECTIMUNE BASED INFLUENZA VACCINES GRANTED IN THE UNITED
STATES
Source text for Eikon: ID:n0001140361-24-012905
Further company coverage: PDSB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PDS Biotechnology
See all newsPDS Biotechnology Corp reports results for the quarter ended September 30 - Earnings Summary
PDS Biotechnology Q3 net loss narrows on lower R&D costs
PDS Biotechnology Corp expected to post a loss of 10 cents a share - Earnings Preview
Brief: PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing
Brief: Pds Biotechnology Corp - On Aug 6, Approved Reduction In Force To Align Expenses With Strategic Priorities - SEC Filing